CANTEL MEDICAL CORP's ticker is CMD and the CUSIP is 138098108. A total of 251 filers reported holding CANTEL MEDICAL CORP in Q3 2019. The put-call ratio across all filers is 1.03 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $6,847,000 | -7.8% | 96,585 | -2.7% | 0.25% | -13.9% |
Q3 2019 | $7,425,000 | -7.9% | 99,267 | -0.7% | 0.30% | -10.9% |
Q2 2019 | $8,064,000 | +18.1% | 100,002 | -2.0% | 0.33% | +13.4% |
Q1 2019 | $6,829,000 | +15.5% | 102,088 | +28.5% | 0.29% | -0.7% |
Q4 2018 | $5,912,000 | -18.9% | 79,420 | +0.3% | 0.29% | -3.3% |
Q3 2018 | $7,293,000 | -5.6% | 79,220 | +0.8% | 0.30% | -12.4% |
Q2 2018 | $7,726,000 | -14.0% | 78,554 | -2.5% | 0.35% | -17.0% |
Q1 2018 | $8,979,000 | +7.6% | 80,599 | -0.6% | 0.42% | +12.1% |
Q4 2017 | $8,343,000 | +10.1% | 81,099 | +0.8% | 0.37% | +1.9% |
Q3 2017 | $7,579,000 | +15.0% | 80,484 | -4.9% | 0.37% | +12.6% |
Q2 2017 | $6,590,000 | +3083.6% | 84,590 | +3172.3% | 0.32% | +1931.2% |
Q1 2017 | $207,000 | -94.7% | 2,585 | -96.5% | 0.02% | -93.1% |
Q2 2015 | $3,933,000 | +14.5% | 73,286 | +1.3% | 0.23% | +4.5% |
Q1 2015 | $3,436,000 | +9.4% | 72,331 | -0.4% | 0.22% | +6.7% |
Q4 2014 | $3,141,000 | +26.8% | 72,596 | +0.7% | 0.21% | +22.4% |
Q3 2014 | $2,478,000 | – | 72,089 | – | 0.17% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DIKER MANAGEMENT LLC | 1,805,250 | $61,144,000 | 18.90% |
Brown Capital Management | 4,069,141 | $137,822,000 | 2.95% |
Kimelman & Baird, LLC | 364,514 | $12,346,000 | 2.60% |
Teton Advisors, Inc. | 396,782 | $13,439,000 | 1.18% |
Ranger Investment Management | 565,995 | $19,170,000 | 0.93% |
Geller Advisors LLC | 26,043 | $882,000 | 0.75% |
CONNORS INVESTOR SERVICES INC | 57,826 | $1,959,000 | 0.63% |
Boston Trust Walden Corp | 733,798 | $24,853,000 | 0.40% |
MISSOURI VALLEY PARTNERS, INC. | 24,481 | $829,000 | 0.32% |
GENEVA CAPITAL MANAGEMENT LLC | 451,958 | $15,307,000 | 0.31% |